Immunization News and Research

RSS

WHO prioritizes candidate vaccines and therapeutics for Bundibugyo virus

In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic of the Congo, with cases also reported in Uganda, WHO convened several of its expert and advisory groups.

29 May 2026

Scientists urge advocacy to protect vital global vaccine research

Scientists and physicians should advocate to protect the vaccine research infrastructure that has saved an estimated 154 million lives over the past 50 years, according to a new commentary by researchers at Weill Cornell Medicine and the University of Washington.

22 May 2026

PAHO and The Carter Center join hands on the elimination of onchocerciasis across the Americas

The Pan American Health Organization (PAHO) and The Carter Center signed a Technical Cooperation Agreement today to strengthen collaboration on the elimination of onchocerciasis — also known as river blindness — and other communicable diseases in the Americas.

21 May 2026

Adjuvanted and high-dose flu vaccines protect older adults equally well

In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant difference in protection against PCR-confirmed influenza. The findings support current recommendations that both enhanced vaccines are reasonable options for older adults, while second-season results may further refine the evidence.

20 May 2026

A century of safety: Aluminium vaccine adjuvants do not raise serious long-term health risks

A BMJ systematic review of 59 human studies found no evidence supporting causal links between aluminum-adjuvanted vaccines and serious or long-term outcomes such as autism spectrum disorder, asthma, autoimmune conditions, or other chronic illnesses. The most consistent adverse events were uncommon, local, self-limited persistent nodules or granulomas, likely reflecting delayed-type hypersensitivity.

11 May 2026

U.S. fails key measles elimination indicators amid rising outbreaks

After public health experts declared measles eliminated in the U.S. in 2000, the U.S. Center for Disease Control and Prevention (CDC) established seven indicators of measles elimination status to ensure that the country remained on track.

30 Apr 2026

HPV infections continue after age 27, so who is still at risk?

HPV infections in women aged 27+ highlight the need for updated vaccination policies, emphasizing ongoing risk and the importance of preventive healthcare.

30 Apr 2026

Maternal antibodies provide lifelong protection against adult gum disease

Mothers provide a hidden immune legacy that protects their children's teeth long after weaning is over. A new study reveals how maternal antibodies act as early life architects, programming the mouth to resist aggressive bacteria and prevent the bone loss associated with adult gum disease.

29 Apr 2026

Delaying hepatitis B birth vaccines increases infant infection risks

Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life, according to a new Cornell University study.

27 Apr 2026

The Big Catch-Up reaches millions of children with life-saving vaccines

The Big Catch-Up (BCU), a historic multi-year, multi-country effort to address vaccination declines driven largely by the COVID-19 pandemic, has reached an estimated 18.3 million children aged 1 to 5 across 36 countries with more than 100 million doses of life-saving vaccines, helping to narrow critical immunity gaps, announced Gavi, the Vaccine Alliance (Gavi), WHO, and UNICEF at the start of World Immunization Week.

24 Apr 2026

Study highlights the fragility of measles elimination in the United States

A new study examined measles vaccination coverage following a large postelimination outbreak, primarily affecting unvaccinated children. Findings from the study will be presented during the Pediatric Academic Societies (PAS) 2026 Meeting, taking place April 24-27 in Boston.

24 Apr 2026

Rising rotavirus cases highlight importance of childhood vaccination

With a rising number of rotavirus cases being reported across the country and in New Jersey this spring, experts from Hackensack Meridian Children's Health are urging parents to ensure their children are vaccinated against this common and potentially severe illness.

21 Apr 2026

Why Japan saw a major pertussis surge in 2025 while other countries peaked earlier

This study found that pertussis cases fell across Japan, Australia, New Zealand, China, and the USA during COVID-19 restrictions, then resurged afterward, with most countries peaking in 2024 but Japan showing a delayed major outbreak in 2025. In Japan, the surge was concentrated in school-aged children and adolescents, highlighting possible gaps in booster protection and the need to reassess immunization strategies.

20 Apr 2026

What still drives childhood vaccine gaps in the United States

A nationwide analysis of provider-verified NIS-Child data from 2010 to 2023 found that US childhood vaccination coverage remained generally high but was consistently shaped by social and structural factors such as maternal education, income, insurance, language, and region. The study also showed that coverage of the combined seven-vaccine series rose over time, yet persistent disparities remained, especially for vaccines such as influenza, hepatitis A, and rotavirus.

19 Apr 2026

Sudan accounts for the world’s largest ongoing humanitarian health crisis

After three years of war, Sudan now accounts for the world's largest humanitarian crisis, with 34 million people needing aid, 21 million lacking health services, and repeated attacks crippling a medical system already weakened by disease and hunger.

15 Apr 2026

ProImmune collaborates with The University of Texas Medical Branch to advance infectious disease research

ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases.

From ProImmune Ltd. 15 Apr 2026

Flu vaccines protect children well across Europe, but H3N2 remains harder to stop

Influenza vaccination provided strong real-world protection for children in European primary care across two seasons, with overall vaccine effectiveness of 68% in 2022–2023 and 71% in 2023–2024. Protection was highest against influenza B and H1N1, while H3N2 showed lower and more variable effectiveness, supporting the need for higher uptake and continued monitoring.

8 Apr 2026

New monoclonal antibody shows promise for preventing Lyme disease

A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the prevention of Lyme disease in the U.S. was well tolerated and showed lasting serum concentrations in participants, according to data presented by Mark Klempner, MD, at the World Vaccine Congress 2026 in Washington D.C.

8 Apr 2026

Declining booster uptake after vaccine schedule change in England

The change to a 1+1 pneumococcal vaccine schedule in England highlights rising inequalities in booster uptake, threatening protection for at-risk children.

7 Apr 2026

World Health Day 2026: WHO urges global collaboration and science for better health

The World Health Organization (WHO) today calls on people everywhere to renew their commitment to working together and supporting science as the twin engines driving better health, under the World Health Day 2026 theme: "Together for health. Stand with science."

6 Apr 2026